Intuitive Surgical (ISRG) Income from Non-Controlling Interests (2017 - 2026)
Intuitive Surgical (ISRG) posted Income from Non-Controlling Interests of $6.6 million for Q2 2026, up 32.0% on a QoQ basis from $5.0 million in Q1 2026, and up 8.2% year-over-year from $6.1 million in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Income from Non-Controlling Interests (2017 - 2026) Analysis & Trends
Intuitive Surgical has reported Income from Non-Controlling Interests for 10 years, with the latest figure at $6.6 million in Q2 2026.
- On a quarterly basis, Income from Non-Controlling Interests rose 8.2% year-over-year to $6.6 million in Q2 2026; TTM through Jun 2026 was $20.7 million, a 4.55% increase from a year earlier, with the FY2025 full-year figure at $20.6 million, up 38.26% from the prior year.
- Income from Non-Controlling Interests was $6.6 million for Q2 2026 at Intuitive Surgical, up from $5.0 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $11.8 million in Q4 2022, with the low at -$800000.0 in Q3 2022.
- Average Income from Non-Controlling Interests over 5 years is $4.9 million, with a median of $5.0 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Income from Non-Controlling Interests tumbled 111.94% in 2022, then surged 612.5% in 2023.
- Over 5 years, Income from Non-Controlling Interests stood at $11.8 million in 2022, then slumped by 61.86% to $4.5 million in 2023, then plunged by 48.89% to $2.3 million in 2024, then surged by 78.26% to $4.1 million in 2025, then surged by 60.98% to $6.6 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $6.6 million (Q2 2026), $5.0 million (Q1 2026), and $4.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -500,000.00 |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | - |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | - |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | - |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 900,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.60 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 4.10 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 6.10 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 4.50 Mn |
| Sep 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 5.20 Mn |
| Mar 31, 2023 | 5.80 Mn |
| Dec 31, 2022 | 11.80 Mn |
| Sep 30, 2022 | -800,000.00 |
| Jun 30, 2022 | 5.80 Mn |
| Mar 31, 2022 | 4.20 Mn |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | 6.70 Mn |